Key Points at a Glance
- A coalition of businesses selling synthetic-nicotine vape products has appealed to the U.S. Court of Appeals for the Fifth Circuit, challenging a Mississippi law restricting vape sales.
- The disputed House Bill 916 took effect in July 2025 and bans the sale of e-cigarette products containing synthetic nicotine in the state.
- The plaintiffs argue the law effectively conditions sales on FDA authorization, in violation of the federal preemption principle.
- A federal district court previously denied a request for a temporary injunction and dismissed the case without prejudice for lack of standing.
2Firsts, December 17, 2025 — According to Law360, a coalition of companies selling e-cigarette products containing synthetic nicotine has appealed a Mississippi state law restricting vape sales to the U.S. Court of Appeals for the Fifth Circuit, seeking to overturn a federal district court’s earlier refusal to temporarily block enforcement of the statute. The companies argue that the state law is preempted by federal law under the Supremacy Clause and is therefore invalid.
Earlier this week, the U.S. District Court for the Southern District of Mississippi rejected the plaintiffs’ request.
According to the complaint and court filings, the plaintiffs include the Vapor Technology Association, the MS Small VTC Business Association, and several retailers. On Monday, the groups filed a notice stating that they would ask the Fifth Circuit to reconsider their bid to prevent Mississippi from enforcing House Bill 916.
The law took effect in July 2025 and explicitly prohibits the sale of e-cigarette products containing synthetic nicotine within the state. State authorities began enforcing penalties, including product confiscations and criminal sanctions, in October, and launched civil enforcement actions in late November.
The plaintiffs contend that the statute effectively bans the sale of any e-cigarette products not authorized by the U.S. Food and Drug Administration. Allowing Mississippi officials to enforce what are effectively FDA regulatory standards would, they argue, usurp federal authority and violate the U.S. Constitution’s Supremacy Clause. The lawsuit further argues that the FDA has deliberately adopted a case-by-case enforcement approach for unauthorized vaping products to balance public health objectives, including helping adult smokers quit cigarettes.
The defendant in the case is Chris Graham, Commissioner of the Mississippi Department of Revenue.
Cover image source: Law360
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
